Mary D. DiBiase
7Patents
3h-index
4Co-inventors
46Inventor score
Filing activity: Jan 11, 2006 → Aug 25, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8932574B2 | Stable liquid interferon beta formulations | Chemistry; Metallurgy | 6 | Active |
| US8512691B2 | Stable liquid interferon-beta formulations | Chemistry; Metallurgy | 5 | Active |
| US9522174B2 | Stable liquid interferon beta formulations | Chemistry; Metallurgy | 3 | Active |
| US8512692B2 | Methods of treating multiple sclerosis with stable liquid interferon-beta formulations | Chemistry; Metallurgy | 2 | Active |
| US10220074B2 | Method for delivering interferon-beta | Human Necessities | 0 | Active |
| US9452106B2 | Method for delivering interferon-β | Human Necessities | 0 | Active |
| US8784399B2 | Method for delivering interferon-β | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.